NCT02000908View on ClinicalTrials.gov

Photobiomodulation Therapy Using the Realief Therapy System for the Treatment of Chemotherapy-associated Peripheral Neuropathy

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 7, 2016

Study Completion Date

January 6, 2017

Conditions
Chemotherapy-induced Peripheral Neuropathy
Interventions
DEVICE

photobiomodulation

The photobiomodulation delivered by Realief Therapy involves amplitude wavelength light delivered by a class IV therapeutic laser.

OTHER

Sham treatment

All patients in sham treatment arm cross over to laser therapy followed by physiotherapy

OTHER

Physiotherapy

Chiropractic massage and lymphedema treatment

Trial Locations (1)

55455

University of Minnesota Gynecologic Cancer Center, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT02000908 - Photobiomodulation Therapy Using the Realief Therapy System for the Treatment of Chemotherapy-associated Peripheral Neuropathy | Biotech Hunter | Biotech Hunter